Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4637808
Max Phase: Preclinical
Molecular Formula: C51H64N4O13
Molecular Weight: 941.09
Molecule Type: Unknown
Associated Items:
ID: ALA4637808
Max Phase: Preclinical
Molecular Formula: C51H64N4O13
Molecular Weight: 941.09
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC(C)N1CCN(c2cc(O)c3nc4c5c6c7c(C)c(O)c5c(=O)c(c-4oc3c2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C/O[C@@](C)(O7)C6=O)CC1
Standard InChI: InChI=1S/C51H64N4O13/c1-12-26(4)54-17-19-55(20-18-54)32-22-33(57)39-35(23-32)67-48-40(52-39)36-37-44(60)30(8)47-38(36)49(62)51(10,68-47)65-21-16-34(64-11)27(5)46(66-31(9)56)29(7)43(59)28(6)42(58)24(2)14-13-15-25(3)50(63)53-41(48)45(37)61/h13-16,21-24,26-29,34,42-43,46,57-60H,12,17-20H2,1-11H3,(H,53,63)/b14-13+,21-16+,25-15-/t24-,26?,27+,28+,29+,34-,42-,43+,46+,51-/m0/s1
Standard InChI Key: LIERTHOGCYDXMI-RZHLIOQJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 941.09 | Molecular Weight (Monoisotopic): 940.4470 | AlogP: 6.58 | #Rotatable Bonds: 5 |
Polar Surface Area: 230.66 | Molecular Species: ZWITTERION | HBA: 16 | HBD: 5 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.52 | CX Basic pKa: 8.61 | CX LogP: 4.53 | CX LogD: 2.94 |
Aromatic Rings: 2 | Heavy Atoms: 68 | QED Weighted: 0.08 | Np Likeness Score: 1.39 |
1. Bera S, Mondal D.. (2019) Insights of synthetic analogues of anti-leprosy agents., 27 (13): [PMID:31103404] [10.1016/j.bmc.2019.04.032] |
2. Bera S, Mondal D.. (2019) Insights of synthetic analogues of anti-leprosy agents., 27 (13): [PMID:31103404] [10.1016/j.bmc.2019.04.032] |
Source(1):